Sinopharm Jiankun Medical Co., Ltd. announced that it expects to receive CNY 27.7474 million in funding from China National Medicines Corporation Ltd.
Sinopharm Jiankun (Beijing) Medical Co., Ltd. announced that it will receive CNY 27,747,400 in a round of funding on October 23, 2019. The transaction will include participation from returning investor from China National Medicines Corporation Ltd. (SHSE:600511). Prior to the transaction, registered capital of the company is CNY 20,000,000. Post closing, the investor will continue to hold 51% stake in the company. The transaction has been approved in the 17th meeting of the 7th directorate of the investor.